F Cressier

Overview

Explore the profile of F Cressier including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 8

Citations 122

Followers 0

Related Specialties

Endocrinology

Biochemistry

Pharmacology

Top 10 Co-Authors

J M Wood

K G Hofbauer

L Criscione

C Collober-Maugeais

E Pecher

S Ristic

C Egleme

P Tang

T D Luu

M A Baron

Published In

Diabetes Obes Metab

Br J Pharmacol

Eur J Pharmacol

Biochem Biophys Res Commun

Regul Pept

Affiliations

Soon will be listed here.

Recent Articles

Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results

Ristic S, Collober-Maugeais C, Cressier F, Tang P, Pecher E

Diabetes Obes Metab . 2007 Jun; 9(4):506-11. PMID: 17587393

Aim: To compare long-term efficacy and safety of nateglinide plus metformin with those of gliclazide plus metformin in patients with type 2 diabetes not adequately controlled with metformin monotherapy. Methods:...

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes

Rosenstock J, Kim S, Baron M, Camisasca R, Cressier F, Couturier A, et al.

Diabetes Obes Metab . 2007 Feb; 9(2):175-85. PMID: 17300593

Aim: The aim of this study was to compare efficacy and tolerability of initial combination therapy with vildagliptin/pioglitazone to component monotherapy. Methods: This 24-week, multicentre, randomized, double-blind, active-controlled study assessed...

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone

Ristic S, Collober-Maugeais C, Pecher E, Cressier F

Diabet Med . 2006 Jul; 23(7):757-62. PMID: 16842480

Aim: To compare the effects of nateglinide plus metformin with gliclazide plus metformin on glycaemic control in patients with Type 2 diabetes. Methods: Double-blind, double-dummy, parallel group, randomized, multicentre study...

Mechanism of interaction between neuropeptide Y and angiotensin II in the rabbit femoral artery

Cressier F, Criscione L, Hofbauer K

Eur J Pharmacol . 1995 Jan; 272(1):57-65. PMID: 7713150

Neuropeptide Y has direct vasoconstrictor actions and potentiates the effects of other vasoconstrictor agents. To find out whether both effects of neuropeptide Y are mediated via the same receptor and...

Interactions between NPY and its receptor: assessment using ant-NPY antibodies

Grouzmann E, Cressier F, Walker P, HOFBAUER K, Waeber B, Brunner H

Regul Pept . 1994 Dec; 54(2-3):439-44. PMID: 7716277

The present data show that monoclonal antibodies (NPY02, NPY03, NPY04, NPY05) directed against 4 distinct epitopes on NPY may have different actions on NPY binding and NPY-induced cellular responses. NPY02...

Influence of NG-monomethyl-L-arginine on endothelium-dependent relaxations in the perfused mesenteric vascular bed of the rat

Ebeigbe A, Cressier F, Konneh M, Luu T, Criscione L

Biochem Biophys Res Commun . 1990 Jun; 169(3):873-9. PMID: 2363729

Endothelium-dependent relaxation mediated by the formation of nitric oxide (NO) from L-arginine, is prevented by the arginine analog NG-monomethyl L-arginine (L-NMMA) (Palmer et al., Biochem. Biophys. Res. Comm. 153:1251-1256 (1988))....

Local formation of angiotensin II in the rat aorta: effect of endothelium

Egleme C, Cressier F, Wood J

Br J Pharmacol . 1990 Jun; 100(2):237-40. PMID: 2198975

1. The local formation of angiotensin II (AII) from its precursors, angiotensin I (AI) and tetradecapeptide (TDP) renin substrate, was studied in intact (with endothelium) and rubbed (without endothelium) aortic...

Local generation of angiotensin II in the isolated rat aorta

Egleme C, Cressier F, Ashworth C, Hofbauer K, Wood J

J Hypertens Suppl . 1989 Dec; 7(6):S214-5. PMID: 2698928

No abstract available.